[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Insulet Corp (PODD)

Insulet Corp (PODD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,060,489
  • Shares Outstanding, K 69,354
  • Annual Sales, $ 2,708 M
  • Annual Income, $ 247,100 K
  • EBIT $ 516 M
  • EBITDA $ 606 M
  • 60-Month Beta 1.10
  • Price/Sales 3.71
  • Price/Cash Flow 22.89
  • Price/Book 7.06

Options Overview Details

View History
  • Implied Volatility 44.47% (+0.05%)
  • Historical Volatility 72.18%
  • IV Percentile 50%
  • IV Rank 53.84%
  • IV High 62.95% on 07/30/26
  • IV Low 22.92% on 08/22/25
  • Expected Move (DTE 8) 5.19 (3.59%)
  • Put/Call Vol Ratio 1.52
  • Today's Volume 680
  • Volume Avg (30-Day) 925
  • Put/Call OI Ratio 0.92
  • Today's Open Interest 17,978
  • Open Int (30-Day) 9,792
  • Expected Range 139.23 to 149.60

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $1.59
  • Number of Estimates 8
  • High Estimate $1.66
  • Low Estimate $1.50
  • Prior Year $1.24
  • Growth Rate Est. (year over year) +28.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
126.40 +14.94%
on 08/05/26
172.91 -15.98%
on 07/28/26
-16.78 (-10.35%)
since 07/13/26
3-Month
126.40 +14.94%
on 08/05/26
172.91 -15.98%
on 07/28/26
-3.56 (-2.39%)
since 05/13/26
52-Week
126.40 +14.94%
on 08/05/26
354.88 -59.06%
on 11/20/25
-163.40 (-52.94%)
since 08/13/25

Most Recent Stories

More News
PODD DEADLINE: SueWallSt Reminds Insulet Corporation Investors of Upcoming Securities Class Action Deadline

Alert: Claims Focus on Alleged Defective Cannula Manufacturing That Caused Insulin Under-Delivery in Millions of Omnipod Devices

PODD : 145.61 (+0.38%)
Pomerantz Law Firm Announces the Filing of a Class Action Against Insulet Corporation and Certain Officers - PODD

NEW YORK , Aug. 13, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Insulet Corporation ("Insulet" or the "Company") (NASDAQ: PODD) and certain officers.  ...

PODD : 145.61 (+0.38%)
Insulet Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PODD

LOS ANGELES , Aug. 13, 2026 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against Insulet Corporation ("Insulet" or "the Company") (NASDAQ: PODD ) for violations...

PODD : 145.61 (+0.38%)
Insulet Corporation Investor Alert: Contact SBS by August 31, 2026 for Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , Aug. 13, 2026 /PRNewswire/ -- Schall Brown & Schwartz LLP , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Insulet Corporation...

PODD : 145.61 (+0.38%)
5 Must-Read Analyst Questions From Insulet’s Q2 Earnings Call

5 Must-Read Analyst Questions From Insulet’s Q2 Earnings Call

PODD : 145.61 (+0.38%)
Insulet Corporation (PODD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , Aug. 11, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP  announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against...

PODD : 145.61 (+0.38%)
PODD DEADLINE: The Gross Law Firm Reminds Insulet Corporation Investors of Upcoming Securities Class Action Deadline

NEW YORK , Aug. 11, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of  Insulet Corporation (NASDAQ: PODD).

PODD : 145.61 (+0.38%)
Insulet Corporation (PODD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , Aug. 10, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith  announces that investors with substantial losses have opportunity to lead the securities fraud class action...

PODD : 145.61 (+0.38%)
Insulet Corporation Investor Alert: Contact SBS by August 31, 2026 for Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , Aug. 10, 2026 /PRNewswire/ -- Schall Brown & Schwartz LLP , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Insulet Corporation...

PODD : 145.61 (+0.38%)
Insulet Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PODD

LOS ANGELES , Aug. 10, 2026 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against Insulet Corporation ("Insulet" or "the Company") (NASDAQ: PODD ) for violations...

PODD : 145.61 (+0.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System...

See More

Key Turning Points

3rd Resistance Point 154.42
2nd Resistance Point 150.01
1st Resistance Point 147.53
Last Price 145.61
1st Support Level 140.64
2nd Support Level 136.23
3rd Support Level 133.75

See More

52-Week High 354.88
Fibonacci 61.8% 267.60
Fibonacci 50% 240.64
Fibonacci 38.2% 213.68
Last Price 145.61
52-Week Low 126.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.